| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |